D-0362-2024 Class II Ongoing

Recalled by Denver Solutions, LLC DBA Leiters Health — Englewood, CO

FDA drug recall D-0362-2024 was initiated by Denver Solutions, LLC DBA Leiters Health on Feb 20, 2024 and is designated Class II. Reason for recall: Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination. The recall status is ongoing. Affected quantity: 10,020 vials.

Recall details

Product Type
Drugs
Report Date
Mar 6, 2024
Initiation Date
Feb 20, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10,020 vials

Product description

Moxifloxacin 5mg/ml, 1 ml in a Single- Dose Vial, Rx Only, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-097-42

Reason for recall

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Distribution pattern

Nationwide in the USA

Code information

Lot #:2331123, Exp:28-Feb-24; 2331298, Exp: 24-Mar-24.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0362-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0362-2024. Report a data issue: hello@regdatalab.com.